Done sou Salè H1B

Akèy › Anplwayè › Avance Clinical LLC

Avance Clinical LLC: Salè H-1B ak pajon

Avance Clinical LLC depoze 4 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 4. Medyèn salè yo ofri a: $118,980.

Demann (LCA)4
Certifye4
Adrès anplwayèSeattle, WA
Salè medyan ofri$118,980
Mwatye salè yo$96,720–$135,000
10yèm–90yèm pousantaj$85,488–$135,000

Èske Avance Clinical LLC pajone visa H-1B?

Avance Clinical LLC depoze 4 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 20, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.

Salè pa tit travay

Tit travayLCASalè medyan
Principal Clinical Research Associate2$135,000
Team Lead, Drug Safety Services1$78,000
Senior Manager, Safety Services1$102,960

Aplikasyon pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$78,000
FY20241$135,000
FY20251$135,000
FY20261$102,960

Nivo salè prevanlan

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Kote travay yo ye

Okipasyon

Dènye aplikasyon yo

Tit travaySalè bazKoteSoumètDat kòmansmanEstati
Senior Manager, Safety Services$102,960
E-3 · Nivo II
Erie, COMay 20, 2025Sep 1, 2025Certifye, apre retire
Principal Clinical Research Associate$135,000
E-3 · Nivo I
Las Vegas, NVApr 16, 2025May 1, 2025Certifye
Principal Clinical Research Associate$135,000
E-3 · Nivo I
Seattle, WAJun 10, 2024Jul 1, 2024Certifye
Team Lead, Drug Safety Services$78,000
E-3 · Nivo II
Erie, COAug 10, 2023Sep 1, 2023Certifye

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).